Clinical Trial Update: Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety [NA]

View source ↗

Summary

A clinical trial evaluating closed-loop neurofeedback targeting the left dorsolateral prefrontal cortex for cardiac autonomic modulation in coronary artery dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Coronary Artery Disease

Snippet

Sponsor: Shenyang Medical College | Conditions: Coronary Heart Disease (CHD), Anxiety Disorders | NA | Status: RECRUITING